In today’s recent session, 0.36 million shares of the Equillium Inc (NASDAQ:EQ) have been traded, and its beta is 1.13. Most recently the company’s share price was $0.35, and it changed around $0.04 or 12.18% from the last close, which brings the market valuation of the company to $12.50M. EQ at last check was trading at a discount to its 52-week high of $1.50, offering almost -328.57% off that amount. The share price’s 52-week low was $0.27, which indicates that the recent value has risen by an impressive 22.86% since then. We note from Equillium Inc’s average daily trading volume that its 10-day average is 0.19 million shares, with the 3-month average coming to 650.13K.
Equillium Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended EQ as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Equillium Inc (NASDAQ:EQ) trade information
Instantly EQ has been showing a green trend so far today with a performance of 12.18% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3460 on recent trading daydecreased the stock’s daily price by -1.16%. The company’s shares are currently down -48.52% year-to-date, but still up 11.11% over the last five days. On the other hand, Equillium Inc (NASDAQ:EQ) is -7.89% down in the 30-day period. We can see from the shorts that 2.09 million shares have been sold at a short interest cover period of 1.4 day(s).
The consensus price target as assigned by Wall Street analysts is $1, which translates to bulls needing to increase their stock price by 65.0% from its current value. Analyst projections state that EQ is forecast to be at a low of $1 and a high of $1.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 31.13%.
EQ Dividends
Equillium Inc’s next quarterly earnings report is expected to be released on 2025-May-14.
Equillium Inc (NASDAQ:EQ)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 35.90% of Equillium Inc shares, and 19.14% of them are in the hands of institutional investors. The stock currently has a share float of 29.86%. Equillium Inc stock is held by 24.0 institutions, with DECHENG CAPITAL LLC being the largest institutional investor. By 2024-06-30, it held 12.6148% of the shares, which is about 4.45 million shares worth $3.08 million.
TAKEDA PHARMACEUTICAL CO LTD, with 5.1711% or 1.82 million shares worth $1.26 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 570.84 shares worth $0.21 million, making up 1.60% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 247.43 shares worth around $89074.0, which represents about 0.69% of the total shares outstanding.
